Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeNCT06050122SLGLPhase 3Completed2026-08-20Actual
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)NCT06051409Ascentage Pharma Group Inc.Phase 3Recruiting2027-12-31Estimated
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexNCT06054217TARSPhase 2Unknown2024-06-15Estimated
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsNCT06056297X4 PharmaceuticalsPhase 3Recruiting2027-09Estimated
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06058013NMRAPhase 3Completed2026-05-06Actual
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNCT06058039NMRAPhase 3Completed2026-05-04Actual
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)NCT06059846Spero TherapeuticsPhase 3Completed2025-01-27Actual
Travoprost Intraocular Implant in Conjunction With Cataract SurgeryNCT06061718Glaukos CorporationPhase 3Unknown2024-03-18Actual
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive GlioblastomaNCT06061809IBRXPhase 2Active not recruiting2029-12-31Estimated
Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyNCT06066580EWTXPhase 2Enrolling by invitation2031-02Estimated
VK2735 for Weight Management Phase 2NCT06068946VKTXPhase 2Completed2024-02-27Actual
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.NCT06072612BriaCell Therapeutics CorporationPhase 3Recruiting2027-12Estimated
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781VSTMPhase 3Recruiting2028-10-15Estimated
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007NCT06075537DNLIPhase 2, Phase 3Enrolling by invitation2027-06Estimated
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping TreatmentNCT06079736PEPGPhase 2Terminated2025-08-28Actual
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)NCT06081894CytokineticsPhase 3Active not recruiting2026-08-31Actual
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT06082167ExelixisPhase 2, Phase 3Active not recruiting2028-08Estimated
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)NCT06087276Praxis Precision MedicinesPhase 3Recruiting2025-10-10Actual
DMT310-009 Topical in the Treatment of Acne VulgarisNCT06090721Dermata TherapeuticsPhase 3Completed2025-03-31Actual
A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseNCT06092034RCKTPhase 2Recruiting2028-06Estimated
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung CancerNCT06095505PBYIPhase 2Recruiting2027-10-30Estimated
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisNCT06097260PLRXPhase 2Terminated2025-04-04Actual
Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene TherapyNCT06100887EWTXPhase 2Active not recruiting2027-03Estimated
Global Trial in APG2575 for Patients With CLL/SLLNCT06104566Ascentage Pharma Group Inc.Phase 3Recruiting2026-12-31Estimated
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationNCT06106308Cardiff OncologyPhase 2Active not recruiting2027-04-16Estimated
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)NCT06108219Corcept TherapeuticsPhase 2Completed2026-02-13Actual
Continuation Study for LatozinemabNCT06111014ALECPhase 3Terminated2025-09-01Actual
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBTNCT06111235CGONPhase 3Active not recruiting2026-11Estimated
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)NCT06112314Immunocore LtdPhase 3Recruiting2027-10-16Estimated
AMX0035 and Progressive Supranuclear PalsyNCT06122662AMLXPhase 2, Phase 3Completed2025-09-30Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.